Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant.

[1]  D. Kreisel,et al.  Maintenance of IKK&bgr; Activity Is Necessary to Protect Lung Grafts From Acute Injury , 2011, Transplantation.

[2]  S. Todo,et al.  Donor pretreatment with DHMEQ improves islet transplantation. , 2010, The Journal of surgical research.

[3]  Chad A Mirkin,et al.  Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles. , 2010, Surgery.

[4]  J. Bluestone,et al.  2007 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry (CITR) , 2009, Cell transplantation.

[5]  D. Kaufman,et al.  The epididymal fat pad as a transplant site for minimal islet mass. , 2007, Transplantation.

[6]  D. Kaufman,et al.  In Vivo Bioluminescence Imaging of Transplanted Islets and Early Detection of Graft Rejection , 2006, Transplantation.

[7]  M. Ko,et al.  Nuclear Factor-κB Activated by Capacitative Ca2+ Entry Enhances Muscarinic Receptor-mediated Soluble Amyloid Precursor Protein (sAPPα) Release in SH-SY5Y Cells* , 2006, Journal of Biological Chemistry.

[8]  Afshin Samali,et al.  Cytoprotection of beta cells: rational gene transfer strategies , 2006, Diabetes/metabolism research and reviews.

[9]  P. Serup,et al.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Hwa‐Jung Kim,et al.  Nuclear factor-kappaB activated by capacitative Ca2+ entry enhances muscarinic receptor-mediated soluble amyloid precursor protein (sAPPalpha) release in SH-SY5Y cells. , 2006, The Journal of biological chemistry.

[11]  A. Shapiro,et al.  Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction. , 2006, Cell transplantation.

[12]  P. Halban,et al.  Activation of NF-κB by Extracellular Matrix Is Involved in Spreading and Glucose-stimulated Insulin Secretion of Pancreatic Beta Cells* , 2005, Journal of Biological Chemistry.

[13]  A. Shapiro,et al.  Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.

[14]  H. Edlund,et al.  Nuclear Factor-κB Activity in β-Cells Is Required for Glucose-Stimulated Insulin Secretion , 2005 .

[15]  H. Edlund,et al.  Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion. , 2005, Diabetes.

[16]  P. Halban,et al.  Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. , 2005, The Journal of biological chemistry.

[17]  H. Tomizawa,et al.  A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. , 2003, Bioorganic & medicinal chemistry.

[18]  D. Kaufman,et al.  Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. , 2003, Surgery.

[19]  D. Kaufman,et al.  Proinflammatory cytokines induce NF-κB-Dependent/NO-independent chemokine gene expression in MIN6 β cells , 2003 .

[20]  C. Mathieu,et al.  IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.

[21]  H. Tomizawa,et al.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation , 2003 .

[22]  A. K. Cardozo,et al.  Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic beta-cells. , 2003, Diabetes.

[23]  C. Mathieu,et al.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. , 2003, Diabetologia.

[24]  D. Kaufman,et al.  Proinflammatory cytokines induce NF-kappaB-dependent/NO-independent chemokine gene expression in MIN6 beta cells. , 2003, The Journal of surgical research.

[25]  H. Tomizawa,et al.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. , 2003, Bioorganic & medicinal chemistry.

[26]  M. Kruhøffer,et al.  A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-κB-dependent Genes in Primary Rat Pancreatic β-Cells* , 2001, The Journal of Biological Chemistry.

[27]  D. Eizirik,et al.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.

[28]  D. Kaufman,et al.  Expression of a Dominant Negative Inhibitor of NF-κB Protects MIN6 β-Cells from Cytokine-Induced Apoptosis☆ , 2001 .

[29]  D. Kaufman,et al.  Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis. , 2001, The Journal of surgical research.

[30]  M. Trucco,et al.  Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB Repressor* , 2000, The Journal of Biological Chemistry.

[31]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[32]  Steffen Jung,et al.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation , 2000, Nature Medicine.

[33]  P. Robbins,et al.  Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. , 2000, The Journal of biological chemistry.

[34]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[35]  D. Goeddel,et al.  Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. , 1999, Immunity.

[36]  B. Vainer,et al.  Interleukin-15 and its role in chronic inflammatory diseases , 1998, Inflammation Research.

[37]  W. Suarez-Pinzon,et al.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. , 1998, Biochemical pharmacology.

[38]  D. Pipeleers,et al.  Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. , 1997, Endocrinology.

[39]  D. Taub,et al.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. , 1995, Journal of immunology.

[40]  S. Nadler,et al.  Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. , 1995, Journal of immunology.

[41]  D. Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.

[42]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[43]  G. B. Wisely,et al.  NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. , 1994, Journal of immunology.

[44]  M. Field,et al.  Effect of 15-Deoxyspergualin on Immediate Function and Long-Term Survival of Transplanted Islets in Murine Recipients of a Marginal Islet Mass , 1994, Diabetes.

[45]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[46]  D. Eizirik,et al.  Treatment With an Interleukin-1 Receptor Antagonist Protein Prolongs Mouse Islet Allograft Survival , 1993, Diabetes.

[47]  D. Dunn,et al.  Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts , 1990, The Journal of experimental medicine.

[48]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[49]  L. Harrison,et al.  IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. , 1988, Journal of immunology.

[50]  E. Leiter,et al.  Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. , 1984, Transplantation.

[51]  R. Assan,et al.  [Functional inhibition of isolated pancreatic cells, new technic for the detection of macrophage cytotoxicity]. , 1978, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.